Trends in global prescribing of antidiabetic medicines in primary care

A systematic review of literature between 2000–2018

Sara Ramzan, Peter Timmins, Syed Shahzad Hasan, Zaheer-Ud-Din Babar

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.
Original languageEnglish
Pages (from-to)409-421
Number of pages13
JournalPrimary Care Diabetes
Volume13
Issue number5
Early online date15 Jun 2019
DOIs
Publication statusPublished - 1 Oct 2019

Fingerprint

Metformin
Hypoglycemic Agents
Type 2 Diabetes Mellitus
Primary Health Care
Databases
Pharmaceutical Preparations

Cite this

@article{eebabdd3990647328718f5db1d7fa192,
title = "Trends in global prescribing of antidiabetic medicines in primary care: A systematic review of literature between 2000–2018",
abstract = "The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.",
author = "Sara Ramzan and Peter Timmins and Hasan, {Syed Shahzad} and Zaheer-Ud-Din Babar",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.pcd.2019.05.009",
language = "English",
volume = "13",
pages = "409--421",
journal = "Primary Care Diabetes",
issn = "1751-9918",
publisher = "Elsevier BV",
number = "5",

}

Trends in global prescribing of antidiabetic medicines in primary care : A systematic review of literature between 2000–2018. / Ramzan, Sara; Timmins, Peter; Hasan, Syed Shahzad; Babar, Zaheer-Ud-Din.

In: Primary Care Diabetes, Vol. 13, No. 5, 01.10.2019, p. 409-421.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Trends in global prescribing of antidiabetic medicines in primary care

T2 - A systematic review of literature between 2000–2018

AU - Ramzan, Sara

AU - Timmins, Peter

AU - Hasan, Syed Shahzad

AU - Babar, Zaheer-Ud-Din

PY - 2019/10/1

Y1 - 2019/10/1

N2 - The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.

AB - The aim of this review was to examine changes in the use of diabetes medicines prescribed to treat type 2 diabetes in the primary care setting. Five electronic databases were searched using strict inclusion/exclusion criteria. The quality of eligible studies was appraised using the Newcastle–Ottawa Scale. Findings show the trend has been away from using sulfonylurea and towards the use of metformin. The introduction of newer drugs has not shifted treatment outcomes and glycaemic control. It was not possible to determine how clinicians make choices about the medicines they prescribe for T2DM, or what influences those choices.

UR - http://www.scopus.com/inward/record.url?scp=85067098423&partnerID=8YFLogxK

U2 - 10.1016/j.pcd.2019.05.009

DO - 10.1016/j.pcd.2019.05.009

M3 - Review article

VL - 13

SP - 409

EP - 421

JO - Primary Care Diabetes

JF - Primary Care Diabetes

SN - 1751-9918

IS - 5

ER -